The author of this “article” needs to lit up and schooled. Clearly they didn’t do enough research. No shocker, Leronlimab didn’t make the list of the top 7 promising Covid drugs. This exemplifies the uphill battle we face getting public exposure.

https://www.yahoo.com/news/world-desperately-...00108.html